GO:0140098 catalytic activity, acting on RNA: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140098 (catalytic activity, acting on RNA) is a molecular function term describing any catalytic activity that modifies RNA, including methylation, deamination, cleavage, and ligation [1,4].
• Enzymes in this class include tRNA methyltransferases such as METTL1-WDR4, adenosine deaminases acting on RNA (ADAR1), and ribozymes such as the hairpin ribozyme [1,3,5].
• ADAR1-mediated A-to-I RNA editing requires dimerization and is essential for regulating viral replication and microRNA processing [5,6,7].
• Disease-associated mutations in ADAR1 impair its deaminase activity, linking this GO term to autoimmune and neurological disorders.
• RNA catalysis is ancient and versatile, with ribozymes and protein enzymes sharing catalytic strategies for RNA modification.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of genes encoding RNA-modifying enzymes [1,8].
Description
GO:0140098, catalytic activity, acting on RNA, is a Gene Ontology molecular function term that encompasses any catalytic activity whose substrate is RNA and whose action modifies that RNA. This broad term captures enzymes and ribozymes that methylate, deaminate, cleave, ligate, or otherwise alter RNA molecules, thereby influencing RNA stability, translation, and regulatory capacity [1,4]. The importance of this term lies in its central role in post-transcriptional gene regulation and its implication in diverse biological processes, from viral defense to neuronal function [5,6,8]. Researchers studying RNA biology rely on this ontology term to annotate and compare the functions of RNA-modifying enzymes across species and experimental conditions. As high-throughput sequencing and CRISPR screening technologies advance, the functional characterization of genes annotated with GO:0140098 has become increasingly tractable, enabling precise mechanistic studies and therapeutic target discovery [1,8].
catalytic activity, acting on RNA At A Glance
| GO ID | GO:0140098 |
|---|---|
| GO term | catalytic activity, acting on RNA |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of chemical modifications to RNA molecules |
| Examples | tRNA methylation, adenosine deamination, RNA cleavage, RNA ligation |
| Related enzymes | METTL1-WDR4, ADAR1, hairpin ribozyme |
| Substrate | RNA |
What Is GO:0140098?
According to the Gene Ontology, GO:0140098 (catalytic activity, acting on RNA) is defined as any catalytic activity that acts to modify RNA. This includes enzymatic activities that add or remove chemical groups, cleave phosphodiester bonds, or join RNA molecules, as long as the substrate is RNA and the reaction is catalytic.
Why Is catalytic activity, acting on RNA Important in Cell Biology?
GO:0140098 is important because RNA modifications catalyzed by its member enzymes regulate nearly every aspect of RNA metabolism, including stability, localization, and translation [1,4]. Dysregulation of these activities is linked to viral infections, cancer, and neurological disorders, making them attractive targets for therapeutic intervention and biomarker development [5,8].
• RNA modifications control gene expression post-transcriptionally.
• ADAR1-mediated editing is critical for innate immune response to viruses [5,6].
• tRNA methylation by METTL1-WDR4 affects translation efficiency and cell growth.
• Ribozymes demonstrate RNA's intrinsic catalytic versatility [3,4].
• Mutations in ADAR1 are associated with autoimmune and neurological diseases.
• RNA-modifying enzymes are potential drug targets in oncology [1,8].
• CRISPR screens can identify novel genes with catalytic activity on RNA.
• Understanding these enzymes aids in designing RNA-based therapeutics.
What Happens During catalytic activity, acting on RNA?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs the RNA it needs to modify.
Enzymes with catalytic activity on RNA must first recognize and bind their RNA substrates with high specificity. For example, the METTL1-WDR4 complex recognizes tRNA structures to methylate specific nucleotides. ADAR1 binds double-stranded RNA regions to catalyze adenosine-to-inosine editing.
Catalytic modification
In simple terms: The enzyme performs the chemical reaction that changes the RNA.
Once bound, the enzyme catalyzes a chemical modification. METTL1-WDR4 transfers a methyl group to tRNA. ADAR1 deaminates adenosine to inosine in RNA [5,7]. Ribozymes such as the hairpin ribozyme catalyze RNA cleavage and ligation through transesterification.
Product release and downstream effects
In simple terms: The modified RNA is released and can now do its job differently.
After modification, the RNA is released and its altered structure or sequence affects downstream processes. For instance, ADAR1 editing of microRNA-122 enhances its processing and inhibits hepatitis B virus replication. tRNA methylation by METTL1-WDR4 influences translation.
Key Genes Involved in GO:0140098 catalytic activity, acting on RNA
The following genes encode proteins or RNAs with catalytic activity acting on RNA, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL1 | tRNA methylation | Structural and mechanistic studies of RNA modification |
| WDR4 | Partner of METTL1 for tRNA methylation | Required for METTL1 catalytic activity |
| ADAR1 | Adenosine deaminase acting on RNA | RNA editing, viral defense, microRNA processing [5,6,7,8] |
| ADAR2 | Adenosine deaminase acting on RNA | RNA editing in neurons |
| BRCA1 | DNA repair, potential RNA-related functions | Biomarker for breast cancer prognosis |
| BRCA2 | DNA repair, potential RNA-related functions | Biomarker for breast cancer prognosis |
| hairpin ribozyme | RNA cleavage and ligation | Model for RNA catalysis |
| spliceozyme | Engineered ribozyme for splicing | Tool for RNA modification |
| OV20.0 | Orf virus protein interacting with ADAR1 | Viral replication enhancement |
| microRNA-122 | Regulated by ADAR1 editing | Hepatitis B virus replication |
| tRNA | Substrate for methylation | Translation regulation |
| dsRNA | Substrate for ADAR1 | RNA editing |
| inosine | Product of ADAR1 editing | Altered RNA function |
| N6-methyladenosine | RNA modification product | Not directly cited but related to methylation |
| RNA polymerase | Not directly cited but related to RNA synthesis | Not a direct example of GO:0140098 |
| ribonuclease | RNA cleavage | General example of catalytic activity on RNA |
| RNA ligase | RNA joining | General example of catalytic activity on RNA |
How Is catalytic activity, acting on RNA Regulated?
The catalytic activity of RNA-modifying enzymes is regulated at multiple levels. ADAR1 deaminase activity requires dimerization, and disease-associated mutations can impair this process [7,8]. METTL1-WDR4 complex formation is essential for tRNA methylation, and its activity can be influenced by cellular conditions. Viral proteins such as OV20.0 can modulate ADAR1 function to enhance viral replication.
catalytic activity, acting on RNA and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADAR1 | Autoimmune and neurological disorders | Knock-in of patient mutations |
| ADAR1 | Hepatitis B virus replication | Overexpression in hepatoma cells |
| ADAR1 | Orf virus replication | Knockout in keratinocytes |
| METTL1 | Cancer cell growth | Knockout in cancer cell lines |
| BRCA1/2 | Breast cancer prognosis | Knockout in breast cancer models |
ADAR1 mutations and disease
Mutations in ADAR1 that impair its deaminase activity are associated with autoimmune and neurological disorders, highlighting the importance of RNA editing in human health.
Viral infections
ADAR1 inhibits hepatitis B virus replication by enhancing microRNA-122 processing, while Orf virus protein OV20.0 interacts with ADAR1 to enhance viral replication, demonstrating the role of RNA editing in host-pathogen interactions [5,6].
Cancer
BRCA1 and BRCA2, while primarily DNA repair genes, have been linked to breast cancer prognosis and may have RNA-related functions, though direct catalytic activity on RNA for these proteins is not established in the cited literature.
From catalytic activity, acting on RNA-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does METTL1 methylation affect tRNA stability? | METTL1 knockout cell line |
| How do ADAR1 mutations affect editing? | Point mutation knock-in |
| Can ADAR1 editing be monitored? | Tagged knock-in of ADAR1 |
| Does ADAR1 overexpression inhibit HBV? | Overexpression in hepatoma cells |
| What is the role of ADAR1 dimerization? | Dimerization-deficient mutants |
| Can ribozymes be engineered for splicing? | Hairpin ribozyme variants |
How to Study the catalytic activity, acting on RNA Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | RNA editing events | ADAR1 target identification |
| Cryo-EM | Protein structure | METTL1-WDR4 complex |
| In vitro deaminase assay | Enzymatic activity | ADAR1 mutant analysis |
| Methyltransferase assay | Methylation activity | METTL1 function |
| CRISPR screen | Gene essentiality | Identify RNA modification genes |
| Ribo-seq | Translation efficiency | tRNA methylation effects |
| Mass spectrometry | RNA modifications | Detect methylated nucleotides |
| Northern blot | RNA cleavage | Ribozyme activity |
RNA sequencing and editing detection
RNA-seq can identify A-to-I editing events by comparing genomic and transcriptomic sequences, revealing ADAR1 activity.
Structural biology
Cryo-EM and X-ray crystallography have elucidated the structures of METTL1-WDR4 and ADAR1, providing mechanistic insights [1,7].
Biochemical assays
In vitro deaminase and methyltransferase assays measure catalytic activity of purified enzymes [7,8].
CRISPR screens
Genome-wide CRISPR screens can identify genes required for RNA modification pathways.
How CRISPR Can Be Used to Study GO:0140098 catalytic activity, acting on RNA
Knockout
CRISPR knockout of METTL1 or ADAR1 can abolish their catalytic activity, enabling studies of downstream effects on tRNA methylation or RNA editing [1,8].
Point Mutation
Introducing disease-associated point mutations into ADAR1 via CRISPR can recapitulate loss of deaminase activity and model related disorders.
Knock-in
Knock-in of tagged ADAR1 allows for affinity purification and localization studies, as well as monitoring editing activity in vivo.
Overexpression
Overexpression of ADAR1 in hepatoma cells inhibits hepatitis B virus replication, demonstrating the antiviral role of RNA editing.
How EDITGENE Supports catalytic activity, acting on RNA Research
Researchers studying catalytic activity, acting on RNA-related genes often need to determine whether a candidate gene is causally involved in RNA modification, and CRISPR-based models provide a robust approach for such functional validation.
Contact EDITGENE today to design your custom CRISPR model for catalytic activity, acting on RNA research.
Frequently Asked Questions About catalytic activity, acting on RNA
What is GO:0140098?
GO:0140098 is a Gene Ontology molecular function term for catalytic activity that acts to modify RNA, including methylation, deamination, and cleavage.
What genes are involved in catalytic activity, acting on RNA?
Key genes include METTL1, WDR4, ADAR1, and ADAR2, as well as ribozymes like the hairpin ribozyme [1,3,5,7].
How does ADAR1 edit RNA?
ADAR1 binds double-stranded RNA and deaminates adenosine to inosine, a process requiring dimerization.
What diseases are linked to RNA-modifying enzymes?
Mutations in ADAR1 are associated with autoimmune and neurological disorders, and viral infections can be influenced by ADAR1 activity [5,6,8].
What is the role of METTL1 in RNA modification?
METTL1, in complex with WDR4, methylates tRNA to regulate translation.
Can CRISPR be used to study RNA-modifying enzymes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study genes like ADAR1 and METTL1 [1,8].
What methods detect RNA editing?
RNA-seq and biochemical assays can detect A-to-I editing and methylation events [5,8].
Are there ribozymes with catalytic activity on RNA?
Yes, the hairpin ribozyme and engineered spliceozymes catalyze RNA cleavage and ligation.
How is ADAR1 activity regulated?
ADAR1 activity requires dimerization and can be modulated by viral proteins such as OV20.0 [6,7].
What cell models are available for RNA modification research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell lines for RNA-modifying enzymes [1,5,8].
Conclusion
GO:0140098 (catalytic activity, acting on RNA) represents a fundamental molecular function with broad implications for RNA biology, disease, and therapeutics. Understanding the enzymes and ribozymes that modify RNA provides insights into gene regulation and offers opportunities for intervention. CRISPR-based models and advanced sequencing methods continue to accelerate discoveries in this field [1,4,8].
References
- 1. Ruiz-Arroyo VM et al.. 2023. Structures and mechanisms of tRNA methylation by METTL1-WDR4.. Nature 613(7943):383-390 PMID: 36599982
- 2. Jin TY et al.. 2022. BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma.. Int J Mol Sci 23(7) PMID: 35409110
- 3. Zhu J et al.. 2023. A Hairpin Ribozyme Derived Spliceozyme.. Chembiochem 24(13):e202300204 PMID: 37184100
- 4. Wilson TJ et al.. 2021. The potential versatility of RNA catalysis.. Wiley Interdiscip Rev RNA 12(5):e1651 PMID: 33949113
- 5. Liu G et al.. 2019. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.. J Biol Chem 294(38):14043-14054 PMID: 31366735
- 6. Liao GR et al.. 2019. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.. J Virol 93(7) PMID: 30651363
- 7. Cho DS et al.. 2003. Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.. J Biol Chem 278(19):17093-102 PMID: 12618436
- 8. Karki A et al.. 2024. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.. Biochemistry 63(3):282-293 PMID: 38190734
